Curiox Biosystems Statistics
Total Valuation
Curiox Biosystems has a market cap or net worth of KRW 298.11 billion. The enterprise value is 275.81 billion.
Market Cap | 298.11B |
Enterprise Value | 275.81B |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
Earnings Date | Mar 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Curiox Biosystems has 16.10 million shares outstanding. The number of shares has increased by 28.47% in one year.
Current Share Class | n/a |
Shares Outstanding | 16.10M |
Shares Change (YoY) | +28.47% |
Shares Change (QoQ) | +0.13% |
Owned by Insiders (%) | 17.76% |
Owned by Institutions (%) | 14.02% |
Float | 11.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 49.81 |
PB Ratio | 6.53 |
P/TBV Ratio | 26.93 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -22.29 |
EV / Sales | 46.22 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -27.02 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.17.
Current Ratio | 1.44 |
Quick Ratio | 1.26 |
Debt / Equity | 0.17 |
Debt / EBITDA | n/a |
Debt / FCF | -0.76 |
Interest Coverage | -39.91 |
Financial Efficiency
Return on equity (ROE) is -24.46% and return on invested capital (ROIC) is -13.93%.
Return on Equity (ROE) | -24.46% |
Return on Assets (ROA) | -11.59% |
Return on Capital (ROIC) | -13.93% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.09 |
Inventory Turnover | 1.46 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.91% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -11.91% |
50-Day Moving Average | 20,994.80 |
200-Day Moving Average | 22,263.05 |
Relative Strength Index (RSI) | 44.02 |
Average Volume (20 Days) | 159,665 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Curiox Biosystems had revenue of KRW 5.97 billion and -12.37 billion in losses. Loss per share was -770.97.
Revenue | 5.97B |
Gross Profit | 3.12B |
Operating Income | -12.20B |
Pretax Income | -12.31B |
Net Income | -12.37B |
EBITDA | -10.09B |
EBIT | -12.20B |
Loss Per Share | -770.97 |
Balance Sheet
The company has 30.06 billion in cash and 7.76 billion in debt, giving a net cash position of 22.31 billion or 1,385.83 per share.
Cash & Cash Equivalents | 30.06B |
Total Debt | 7.76B |
Net Cash | 22.31B |
Net Cash Per Share | 1,385.83 |
Equity (Book Value) | 45.66B |
Book Value Per Share | 2,836.14 |
Working Capital | 10.74B |
Cash Flow
In the last 12 months, operating cash flow was -10.16 billion and capital expenditures -49.29 million, giving a free cash flow of -10.21 billion.
Operating Cash Flow | -10.16B |
Capital Expenditures | -49.29M |
Free Cash Flow | -10.21B |
FCF Per Share | -634.21 |
Margins
Gross margin is 52.24%, with operating and profit margins of -204.45% and -207.35%.
Gross Margin | 52.24% |
Operating Margin | -204.45% |
Pretax Margin | -206.23% |
Profit Margin | -207.35% |
EBITDA Margin | -169.08% |
EBIT Margin | -204.45% |
FCF Margin | n/a |
Dividends & Yields
Curiox Biosystems does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -28.47% |
Shareholder Yield | -28.47% |
Earnings Yield | -4.16% |
FCF Yield | -3.42% |
Stock Splits
The last stock split was on August 6, 2024. It was a forward split with a ratio of 2.
Last Split Date | Aug 6, 2024 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Curiox Biosystems has an Altman Z-Score of 6.34.
Altman Z-Score | 6.34 |
Piotroski F-Score | n/a |